tert-butyl 4-(4-acetylphenyl)piperazine-1-carboxylate, 95.0%, 1g

((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(di(naphthalen-1-yl)methanol), 97%, 25g

Nickel(II) Oxide, 99.99%, 25g

8-Bromo-2-methylimidazo[1,2-a]pyridine, 98%, 5g

RiboFlow® Pseudomonas aeruginosa

tert-Butyl 2-oxo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 98%, 250mg

4-Amino-1,2,4-triazole>98.0%(HPLC)(T)250g

(2S,3S)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate, 97%, 500mg

Na-Fmoc-Nb-Fmoc-D-2,3-diaminopropionic acid, 98.0%, 250mg

(3-Fluoro-5-formylphenyl)boronic acid, 97%, 250mg

(2S,5R)-1-BOC-2,5-DIMETHYLPIPERAZINE, 97.0%, 25g

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 0.10 µm, 1 Piece(s)

Ethyl 2-(cyclobutylamino)-2-oxoacetate, 98%, 2g